Hepatitis News

 
 
Share this
 
 
Tuesday, February 25, 2014 - 09:09
NVHR's letter to State Medicaid Directors urging them to use AASLD/IDSA hepatitis C treatment guidelines when making drug formulary decisions.
Friday, February 14, 2014 - 15:45
Attached a press release from WHO, from last week, which raises liver cancer up to the 2nd leading cause of cancer death worldwide (after lung cancer). It was previously 3rd. This is very compelling evidence to use as we strive to include liver cancer more in our messaging and talks with our federal/national partners.
Monday, February 3, 2014 - 14:31
Sample letter for medical providers for insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Monday, February 3, 2014 - 14:28
Read NVHR's letter to medical providers regarding the appeals process to appeal insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Wednesday, November 27, 2013 - 11:22
Martha Saly Leaving Executive Director Post at National Viral Hepatitis Roundtable